follicular lymphoma

Despite FDA hold, Epizyme’s tazemetostat posts positive interim data
Fierce Biotech
Fri, 06/15/18 - 09:53 pm
Epizyme
tazemetostat
follicular lymphoma
FDA
At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA
Xconomy
Fri, 02/9/18 - 09:34 am
Verastem
Infinity Pharma
FDA
duvelisib
CLL
follicular lymphoma
small lymphocytic lymphoma
Celgene shares sink after another PhIII lymphoma flop and J&J steps up for the late-stage BCMA race
Endpoints
Sat, 12/23/17 - 12:04 pm
Celgene
JNJ
clinical trials
Revlimid
follicular lymphoma
Cancer Space Update: Label Expansion for Three Major Drugs
Yahoo/Zacks.com
Fri, 11/17/17 - 11:45 am
cancer
labeling
AstraZeneca
Faslodex
Pfizer
Sutent
kidney cancer
Roche
Gazyva
follicular lymphoma
Why Epizyme Inc.'s Shares Skyrocketed Thursday
Motley Fool
Fri, 06/16/17 - 09:56 am
Epizyme
tazemetost
follicular lymphoma
Roche's Gazyva notches early trial success
BioPharma Dive
Fri, 05/27/16 - 12:51 pm
Roche
Gazyva
clinical trials
rituximab
follicular lymphoma
Roche Holding Moves Ahead in Cancer Drugs Race; Wins Expanded FDA Approval for Gazyva
Bidness, ETC
Sat, 02/27/16 - 09:23 am
Roche
FDA
Gazyva
follicular lymphoma
FDA approves Gilead Sciences' Zydelig for 3 forms of blood cancer
Yahoo/AP
Wed, 07/23/14 - 04:33 pm
FDA
Zydelig
Gilead Sciences
chronic lymphocytic leukemia
follicular lymphoma
small lymphocytic lymphoma
Results from a Randomized Study of REVLIMID® (Lenalidomide) and Rituximab (R2) in Patients with Recurrent Follicular Lymphoma Presented at ASCO
Yahoo/Business Wire
Sun, 06/3/12 - 11:10 am
Revlimid
rituximab
follicular lymphoma
Cellgene
Millennium withdraws cancer drug application
Bizjournals.com
Thu, 10/6/11 - 11:56 am
Millennium
Velcade
follicular lymphoma
JNJ
FDA Approves Rituxan for First-Line Maintenance Use in Follicular Lymphoma
BusinessWire
Sat, 01/29/11 - 11:24 am
Roche Group
Biogen Idec
follicular lymphoma
Rituxan
Spectrum's Zevalin shows positive results in study
Yahoo/AP
Mon, 12/6/10 - 07:26 pm
Zevalin
Spectrum Pharmaceuticals
follicular lymphoma
Phase III Study Showed Rituxan® for Initial Use Followed by Continued Use Delayed the Need for Additional Therapy in People with Asymptomatic Follicular Lymphoma, a Common Type of Blood Cancer
Yahoo/BusinessWire
Sun, 12/5/10 - 11:43 am
Rituxan
follicular lymphoma
Roche/Genentech
Biogen Idec
Roche Aims to Expand Rituxan Label
Yahoo/Zacks
Sat, 04/10/10 - 11:37 am
Roche
Rituxan
PRIMA
follicular lymphoma

Pages